Longer ICU Stay and Invasive Mechanical Ventilation Accelerate Telomere Shortening in COVID-19 Patients 1 year After Recovery

Overview

Journal Crit Care

Specialty Critical Care

Date 2024 Aug 7

PMID 39113075

Authors

Ana Virseda-Berdices

Raquel Behar-Lagares

Oscar Martinez-Gonzalez

Rafael Blancas

Soraya Bueno-Bustos

Oscar Brochado-Kith

Eva Manteiga

Maria J Mallol Poyato

Blanca Lopez Matamala

Carmen Martin Parra

Salvador Resino

Maria A Jimenez-Sousa

Amanda Fernandez-Rodriguez

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes virus-induced-senescence. There is an association between shorter telomere length (TL) in coronavirus disease 2019 (COVID-19) patients and hospitalization, severity, or even death. However, it remains unknown whether virus-induced-senescence is reversible. We aim to evaluate the dynamics of TL in COVID-19 patients 1 year after recovery from intensive care units (ICU). Longitudinal study enrolling 49 patients admitted to ICU due to COVID-19 (August 2020 to April 2021). Relative telomere length (RTL) quantification was carried out in whole blood by monochromatic multiplex real-time quantitative PCR (MMqPCR) assay at hospitalization (baseline) and 1 year after discharge (1-year visit). The association between RTL and ICU length of stay (LOS), invasive mechanical ventilation (IMV), prone position, and pulmonary fibrosis development at 1-year visit was evaluated. The median age was 60 years, 71.4% were males, median ICU-LOS was 12 days, 73.5% required IMV, and 38.8% required a prone position. Patients with longer ICU-LOS or who required IMV showed greater RTL shortening during follow-up. Patients who required pronation had a greater RTL shortening during follow-up. IMV patients who developed pulmonary fibrosis showed greater RTL reduction and shorter RTL at the 1-year visit. Patients with longer ICU-LOS and those who required IMV had a shorter RTL in peripheral blood, as observed 1 year after hospital discharge. Additionally, patients who required IMV and developed pulmonary fibrosis had greater telomere shortening, showing shorter telomeres at the 1-year visit. These patients may be more prone to develop cellular senescence and lung-related complications; therefore, closer monitoring may be needed.

References

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

Luppi F, Kalluri M, Faverio P, Kreuter M, Ferrara G . Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respir Res. 2021; 22(1):109. PMC: 8052779. DOI: 10.1186/s12931-021-01711-1. View

Safont B, Tarraso J, Rodriguez-Borja E, Fernandez-Fabrellas E, Sancho-Chust J, Molina V . Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge. Arch Bronconeumol. 2021; 58(2):142-149. PMC: 8414844. DOI: 10.1016/j.arbres.2021.08.014. View

Rossiello F, Jurk D, Passos J, dAdda di Fagagna F . Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022; 24(2):135-147. PMC: 8985209. DOI: 10.1038/s41556-022-00842-x. View

Guerin C, Albert R, Beitler J, Gattinoni L, Jaber S, Marini J . Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med. 2020; 46(12):2385-2396. PMC: 7652705. DOI: 10.1007/s00134-020-06306-w. View

McGroder C, Zhang D, Choudhury M, Salvatore M, DSouza B, Hoffman E . Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax. 2021; 76(12):1242-1245. PMC: 8103561. DOI: 10.1136/thoraxjnl-2021-217031. View

Reyes A, Ortiz G, Duarte L, Fernandez C, Hernandez-Armengol R, Palacios P . Contribution of viral and bacterial infections to senescence and immunosenescence. Front Cell Infect Microbiol. 2023; 13:1229098. PMC: 10518457. DOI: 10.3389/fcimb.2023.1229098. View

de Punder K, Heim C, Wadhwa P, Entringer S . Stress and immunosenescence: The role of telomerase. Psychoneuroendocrinology. 2018; 101:87-100. PMC: 6458519. DOI: 10.1016/j.psyneuen.2018.10.019. View

Nay M, Hindre R, Perrin C, Clement J, Plantier L, Seve A . Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial. Crit Care. 2023; 27(1):240. PMC: 10276908. DOI: 10.1186/s13054-023-04529-z. View

10.

Tahsini Tekantapeh S, Nader N, Ghojazadeh M, Fereidouni F, Soleimanpour H . Prone positioning effect on tracheal intubation rate, mortality and oxygenation parameters in awake non-intubated severe COVID-19-induced respiratory failure: a review of reviews. Eur J Med Res. 2024; 29(1):63. PMC: 10799467. DOI: 10.1186/s40001-024-01661-6. View

11.

Retuerto M, Lledo A, Fernandez-Varas B, Guerrero-Lopez R, Usategui A, Lalueza A . Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities. Immun Ageing. 2022; 19(1):38. PMC: 9394033. DOI: 10.1186/s12979-022-00294-9. View

12.

Chua E, Zahir S, Ng K, Teoh W, Hasan M, Ruslan S . Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis. J Clin Anesth. 2021; 74:110406. PMC: 8216875. DOI: 10.1016/j.jclinane.2021.110406. View

13.

Bellon M, Nicot C . Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection. Viruses. 2017; 9(10). PMC: 5691640. DOI: 10.3390/v9100289. View

14.

Planas-Cerezales L, Arias-Salgado E, Buendia-Roldan I, Montes-Worboys A, Esquinas Lopez C, Vicens-Zygmunt V . Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis. Respirology. 2018; 24(2):146-153. DOI: 10.1111/resp.13423. View

15.

Liang Z, Saugar E, Alamian A, Ferreira T, Downs C . Changes in Telomere Length and Indicators of Oxidative Stress in Critically Ill Mechanically Ventilated Adults - A Pilot Study. Biol Res Nurs. 2022; 25(2):282-288. DOI: 10.1177/10998004221133395. View

16.

Wang C, Lin H, Chang Y, Maa S, Wang J, Tang W . Predictive factors of in-hospital mortality in ventilated intensive care unit: A prospective cohort study. Medicine (Baltimore). 2018; 96(51):e9165. PMC: 5758151. DOI: 10.1097/MD.0000000000009165. View

17.

Hirawat R, Jain N, Saifi M, Rachamalla M, Godugu C . Lung fibrosis: Post-COVID-19 complications and evidences. Int Immunopharmacol. 2023; 116:109418. PMC: 9633631. DOI: 10.1016/j.intimp.2022.109418. View

18.

Froidure A, Mahieu M, Hoton D, Laterre P, Yombi J, Koenig S . Short telomeres increase the risk of severe COVID-19. Aging (Albany NY). 2020; 12(20):19911-19922. PMC: 7655194. DOI: 10.18632/aging.104097. View

19.

Virseda-Berdices A, Concostrina-Martinez L, Martinez-Gonzalez O, Blancas R, Resino S, Ryan P . Relative telomere length impact on mortality of COVID-19: Sex differences. J Med Virol. 2022; 95(1):e28368. PMC: 9878193. DOI: 10.1002/jmv.28368. View

20.

Mulet A, Gonzalez-Cabo P, Pallardo F, Signes-Costa J . Persistent Pulmonary Fibrotic Sequelae in Patients With Telomere Shortening One Year After Severe COVID-19. Arch Bronconeumol. 2023; 60(1):62-64. DOI: 10.1016/j.arbres.2023.11.003. View